Japanese firms ink new business partnership worth ¥5 B for mental healthcare
Japan | News | 0 Comment | 02 Feb, 2022
With the aim of building a regional cooperative mental health platform, Jolly Good Inc. and Otsuka Pharmaceutical h...Read more
Japan grants patent to Anixa Biosciences for ovarian cancer vaccine
Japan | News | 0 Comment | 01 Feb, 2022
US-based Anixa Biosciences, Inc. has announced that the Japanese Patent Office has issued a Decision to Grant ...Read more
Daiichi Sankyo starts trial for mRNA vaccine as booster dose in Japan
Japan | News | 0 Comment | 31 Jan, 2022
Daiichi Sankyo has initiated a trial in Japan to investigate a booster dose of DS-5670, an mRNA vaccine against COVID-19...Read more
Japan's Fujifilm buys Atara’s T-cell manufacturing facility for $100 M
Japan | News | 0 Comment | 27 Jan, 2022
Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies...Read more
Illumina collaborates with National Cancer Center Japan
Japan | News | 0 Comment | 25 Jan, 2022
Illumina, Inc. and the National Cancer Center Japan have announced an international joint research project that wil...Read more
Japan approves VYVGART for treatment of generalised Myasthenia Gravis
Japan | News | 1 Comment | 20 Jan, 2022
Netherlands-based argenx SE has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved ...Read more
Japan’s Daiichi Sankyo divests certain cardiovascular products, shifting focus to oncology
Japan | News | 0 Comment | 19 Jan, 2022
Japan-based pharmaceutical firm Daiichi Sankyo has entered into an agreement with Cosette Pharmaceuticals, Inc. whereby ...Read more
IQVIA releases emerging biotech/biopharma trends to watch for in 2022
Japan | News | 0 Comment | 19 Jan, 2022
IQVIA has come up with the key trends that emerging biotech and emerging biopharma companies should look out for in 2022...Read more
Japan approves MicroPort CRM's Alizea Bluetooth Pacemaker
Japan | News | 0 Comment | 17 Jan, 2022
MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, has recentl...Read more
Japan’s Takeda buys Adaptate Biotherapeutics to strengthen immuno-oncology portfolio
Japan | News | 0 Comment | 11 Jan, 2022
Takeda Pharmaceutical Company has announced the exercise of its option to acquire Adaptate Biotherapeutics, a UK-based c...Read more
Japan develops cancer therapy using on-site synthesis of anti-cancer drugs
Japan | News | 0 Comment | 10 Jan, 2022
An international research group at the RIKEN Cluster for Pioneering Research (CPR) in Japan has successfully treated can...Read more
Japan’s Otsuka Pharma invests in development of psychedelic medicines
Japan | News | 0 Comment | 07 Jan, 2022
The McQuade Center for Strategic Research and Development, LLC (MSRD), established in the US by Japan-based Otsuka Pharm...Read more
Japan's Shimadzu enters into 'smart cells' field with new investment
Japan | News | 0 Comment | 06 Jan, 2022
Japan-based Shimadzu Corporation has invested in Bacchus Bio innovation, a startup company spun off from Kobe University...Read more
Japan's PRISM BioLab partners with Roche and Genentech for drug discovery research
Japan | News | 0 Comment | 05 Jan, 2022
PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...Read more
Japan opts for drug repurposing to stop dementia
Japan | News | 0 Comment | 01 Jan, 2022
Via drug repositioning, a team of scientists at the Osaka City University in Japan has created a combination of rifampic...Read more
Japan-funded study explores antibodies to neutralise omicron
Japan | News | 0 Comment | 28 Dec, 2021
An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. Th...Read more
Merck and Ridgeback’s COVID-19 pill receives ‘special approval’ in Japan
Japan | News | 0 Comment | 27 Dec, 2021
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...Read more
Eisai to market Gilead’s rheumatoid arthritis drug in Asia
Japan | News | 0 Comment | 23 Dec, 2021
Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...Read more